Karyotyping

Karyotyping is the microscopic analysis of the complete set of chromosomes in a cell. Cells are grown in culture, arrested in metaphase and stained with G-banding to produce a characteristic pattern of light and dark bands on each chromosome. It remains the standard test for detecting balanced chromosomal rearrangements.

Karyotyping
Sample Blood (sodium heparin), amniotic fluid, chorionic villi or products of conception
Turnaround Blood 7 to 10 working days; amniotic fluid and chorionic villi 10 to 14 working days
Method G-banding of cultured cells, 400 to 550 bands
Clinical Area Reproductive and Prenatal Genetics; Rare and Inherited Disorders
Clinical Indications Method and Coverage Sample & Preparation Documents & Timing Limitations Results & Counselling Charges & Downloads

Clinical Indications

Diagnostic test in pregnancy. On fetal cells obtained by chorionic villus sampling or amniocentesis, this is a diagnostic test rather than a screening test.

Prenatal

  • Confirmation of a high-chance screening or NIPT result
  • Parental carrier of a balanced rearrangement
  • Follow-up of an abnormal QF-PCR or microarray result

Postnatal & Reproductive

  • Suspected chromosomal syndrome
  • Recurrent pregnancy loss, in both partners
  • Infertility, primary amenorrhoea or azoospermia
  • Differences of sex development
  • Parents of a child or pregnancy with an unbalanced rearrangement

Method & Coverage

Abnormalities Detected

  • Numerical abnormalities, such as trisomy 21, 45,X and 47,XXY
  • Balanced rearrangements, including reciprocal and Robertsonian translocations and inversions
  • Unbalanced structural rearrangements larger than approximately 5 to 10 Mb
  • Marker and ring chromosomes
  • Mosaicism, depending on the number of cells analysed

Method

Cells are cultured, harvested at metaphase and G-banded. A minimum of 20 metaphases is counted and analysed at a band resolution of 400 to 550 bands per haploid set, depending on sample type. Results are reported according to the International System for Human Cytogenomic Nomenclature (ISCN).

Sample & Preparation

  • Peripheral blood: 2 to 3 mL in a sodium heparin tube (1 mL for infants).
  • Amniotic fluid: 15 to 20 mL in sterile containers.
  • Chorionic villi: 15 to 20 mg in sterile transport medium.
  • Products of conception: fresh tissue in sterile transport medium. Do not place in formalin.
  • Transport: room temperature. Do not freeze. Samples should reach the laboratory within 24 hours.
See also general sample requirements and reasons samples may be rejected

Documents & Timing

Documents

  • Label every sample with at least two patient identifiers, matching the requisition form.
  • Include the completed requisition form, clinical information and signed consent.
  • For prenatal samples, include gestational age, ultrasound findings and a maternal EDTA blood sample.

Turnaround Time

  • Peripheral blood: 7 to 10 working days.
  • Amniotic fluid and chorionic villi: 10 to 14 working days.

Limitations

  • Karyotyping requires living, dividing cells. Culture failure can occur, particularly with products of conception.
  • Deletions and duplications smaller than approximately 5 to 10 Mb are not detected.
  • Single-gene disorders are not detected.
  • Low-level mosaicism may be missed.

Results & Counselling

How results are reported

Each report is prepared by a qualified scientist, reviewed independently and signed out by an authorised specialist. Reports state the test performed, the regions analysed, the result and its interpretation, recommendations for follow-up and the limitations of the test.

Report: A signed report is sent to the referring doctor.

Genetic Counselling

A genetic counsellor can explain what this test can and cannot show before it is done, and what the result means once it is available.

Charges & Downloads

Prices depend on the test and clinical situation. Ask our team for current price information.

Request Price Information